As more research and controlled trials become available, we will better understand how to optimize GHK-Cu treatment identifying the best doses, patient types, and protocols
The safety data from animal studies is reassuring
Link to dosing, safety, cost, and comparison guides that support the decision
Typical daily range: 400 mcg (0.4 mg) 1,200 mcg (1.2 mg) total blend once daily, raised gradually across the cycle
Clinical Research Findings In a comprehensive safety analysis published in 2013, researchers evaluated data from six randomized controlled trials spanning five years and involving approximately 900 adult participants
Mean weight reductions from baseline at week 26 were dose-dependent for Cagrilintide